ADARx Pharmaceuticals, Inc. (ADRX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.09B and a free-cash-flow yield of 17.6%. Nama's AI scorecard rates it Slight Buy, 6.0 out of 10.
AI scorecard
Slight Buy · 6.0/10
Positive, but only just — the last rung before Hold. As of Oct 2, 2026.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-21.4%
How far the last close sits under the highest price of the past five years.
Nama's AI scorecard currently rates ADARx Pharmaceuticals, Inc. Slight Buy (6.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
Is ADRX Shariah compliant?
Nama's AAOIFI-style screen reads ADARx Pharmaceuticals, Inc. as Not Shariah Compliant. At least one of the three ratios or the industry test failed.